Lemonaid's Zepbound pricing is the clearest example in this market of a reseller tracking the manufacturer's ladder and adding a membership to it.
Published: Zepbound vials from $299 a month at 2.5 mg, rising to $449 at higher doses, on a $49 monthly membership. LillyDirect publishes $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg — the same numbers, without the $49.
So you are paying $588 a year for the clinical care and the brand. Whether that is reasonable depends entirely on whether you need a prescriber, because LillyDirect does not provide one.
The rest of its branded grid is not competitive
Lemonaid also publishes Ozempic at $1,199 a month and Wegovy at $1,599. Novo Nordisk sells Wegovy directly for $149 as tablets and $349 at maintenance injection doses. That is a difference of over four times for an identical product, and it is worth knowing before you use Lemonaid for anything other than Zepbound.
Its compounded lines follow the same multi-month prepayment structure covered in our compounded tirzepatide review, dropping from $299 to $229 across a six-month commitment.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.
- First month
- $139
- Every month after
- $139
- Total over 12 months
- $1,668
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What Zepbound is, and what it costs at source
Zepbound is tirzepatide, approved by FDA for chronic weight management, and it produced the largest average reductions of any drug in this class — roughly 20 to 21% of body weight over 72 weeks at the highest doses. It is also approved for obstructive sleep apnoea in adults with obesity, which occasionally unlocks coverage where a weight-only prescription would be refused.
Eli Lilly sells it directly. LillyDirect publishes single-dose vials at $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg through 15 mg, with KwikPens across the same range. That is the reference price, and it is close enough to mid-market compounded tirzepatide that the comparison is worth running properly.
Before you buy branded from a reseller
- Check the manufacturer's own price first — NovoCare for Wegovy, LillyDirect for Zepbound. Resale prices range across an order of magnitude.
- Establish whether a membership or programme fee is charged on top of the medication.
- Ask what the price is at your expected maintenance dose, since branded pricing usually rises with dose.
- If you have type 2 diabetes, ask about Ozempic or Mounjaro through insurance before paying cash for anything.
- Confirm whether the provider will submit a prior authorisation, and what happens if it is denied.